›Portfolio Companies

Past, Present and Future Leaders

InterWest is proud and privileged to partner with visionary management teams who are shaping the future of Information Technology and Healthcare. The companies they have started are vital parts of the portfolio of industry-leading startups that InterWest has helped over the last four decades.

Our Companies


2710 Sand Hill Road, Suite 200
Menlo Park, CA 94025, USA
T: 650-854-8585
F: 650-854-4706

Early stage IT and Healthcare Investing

Gil Kliman


Managing Director

"It’s a privilege to work with visionary entrepreneurs who are creating the technologies and procedures that define the future of medical care. And it’s exciting to help them craft business strategies that propel and transform their ideas into market penetration and real-world success."

InterWest Team

Current Investments

Prior Investments

Follow Gil

Gil's bio

Company News


Gil's Buzz

Gil's video

Gil joined InterWest's healthcare team in 1996 and leads the firm's medical device and healthcare IT franchises. He invests in a broad array of healthcare opportunities, with a special interest in ophthalmology, robotics, and physician-centric mobile applications.


He is a board member of Doximity, and a former board member and lead investor in Avedro (NASDAQ: AVDR), Glaukos (NYSE: GKOS), Venus Concept (NASDAQ: VERO) (formerly Restoration Robotics), GoCheck and Neuronetics (NASDAQ: STIM).


Gil has led InterWest's medical device team since 1999 and pioneered InterWest's ophthalmology franchise. He was an early investor in Avedro, Glaukos, LenSx, and IntraLase, category-creating ophthalmic device companies that became standard-of-care for eye surgery around the world. He is also a founder and advisor to the Ophthalmology Innovation Summit, the world's largest ophthalmology business conference with over 2000 annual attendees, and a board member of Orbis International, a global not-for-profit organization focused on preventing blindness.

Gil is also a successful healthcare IT investor, building this important franchise for InterWest over the last fifteen years through multiple companies. He led the Series A of Epocrates, the industry-leading first mobile application for physicians, serving on the board through its 2011 IPO, and was the founding institutional investor in Doximity, helping to build it into the leading physician social network engaging over 70% of U.S. physicians. 


Gil has a B.A. from Harvard University. He received an M.D. from the University of Pennsylvania and an M.B.A. from Stanford University. He completed an ophthalmology residency at Wills Eye Institute and retina fellowship at Massachusetts Eye and Ear Infirmary as a Heed Foundation Fellow.


Representative Prior Investments


Epocrates (NASDAQ: EPOC; acquired by Athenahealth in 2013),  INC Research (acquired by Avista Capital Partners in 2010), Inspire Pharmaceuticals (IPO 2000, ISPH), IntraLase (IPO 2004, ILSE), LenSx Lasers (acquired by Alcon in 2010), Spinal Dynamics (acquired by Medtronic in 2002), Spiration (acquired by Olympus Medical Systems in 2010)

Over the last 20 years I have had the privilege of diverse life experiences as a laser researcher, practicing physician, startup company founder, and technology venture capitalist. I most enjoy being on the front edge of new technology waves, looking over the horizon for non-obvious opportunities... What I find exciting is working alongside visionary entrepreneurs, thinking non-traditionally, and helping to identify creative strategies to make pioneering ventures even more successful.

Facebook Google+ Twitter Email LinkedIn Share